share_log
Benzinga ·  Nov 20 04:46
Mira Pharmaceuticals Announced The Selection Of The Centre For Human Drug Research In Leiden, The Netherlands, As The Site For Its Phase I/IIa Clinical Trial Of Ketamir-2, A Novel Oral Ketamine Analog
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment